Signification of protein p-53 isoforms and immune therapeutic success in chronic lymphocytic leukemia

Publication date: October 2018
Source:Biomedicine & Pharmacotherapy, Volume 106
Author(s): Aurelian Udristioiu, Delia Nica-Badea
In the past few years has used thetechnique for analyzing deletions of genes, its rearrangements, cross-reactivity or multiplications in human genome affected of genetic diseases. Was proved that, the best techniques in the investigation of malignant lymphocytes are the Flow Cytometry, Elisa, ICT and Fluorescence in situ hybridization (FISH). Last method, FISH is used as an alternative to chromosomal banding, a conventional application in molecular medicine and can detect the chromosomal rearrangements and complexes of different genes in malignant diseases, like chronic lymphocytic leukemia (CLL), acute lymphocytic leukemia, (ALL), or multiple myeloma (MM). Identification of P53 gene deletions and mutations in regions of chromosome 17 in hematological malignancies is important because these mutations have an impact on the clinical management of patients.

Graphical abstract

https://ift.tt/2yF4Kpo